Identifying Parkinson's disease biomarkers in gut nerve cells
Official title: Biochemical Characterization of Parkinson's Disease-related Proteins in the Enteric Nervous System as a Proxy for Pathological Changes in the Brain
Run by Weill Medical College of Cornell University · NCT05347407 · Data updated 2026-11-12
This study is trying to see if samples from gut nerve cells can help spot early signs of Parkinson's disease in people aged 45 and older.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 45 Years to 75 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Weill Medical College of Cornell University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | December 30, 2020 |
| Main results expected | June 30, 2028 |
| Study ends | June 30, 2028 |
| Registry record updated | May 22, 2026 |
| Trial ID | NCT05347407 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 45-75 who are at risk for developing Parkinson's disease or have related disorders.
✕Probably not a fit
Patients with other neurodegenerative diseases or significant medical conditions limiting life expectancy may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to explore the relationship between gut nerve cells and Parkinson's disease by examining biomarkers in the microbiome and gut tissue obtained during routine colonoscopy. Participants aged 45 and over will provide samples that may reveal early indicators of Parkinson's disease, potentially leading to earlier diagnosis. The study leverages the accessibility of the enteric nervous system through minimally invasive biopsy, allowing researchers to investigate the connection between gut health and neurological conditions. The findings could enhance our understanding of Parkinson's disease and its onset.
Why it matters
Potential benefit: If successful, this study could lead to earlier diagnosis of Parkinson's disease through the identification of gut biomarkers.
How similar studies have gone: While the approach of examining gut biomarkers in relation to Parkinson's disease is innovative, similar studies have shown promise in linking gut health to neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 45-75 years old * Parkinson's Disease defined by the modified UK Parkinson's Disease Society Brain Bank criteria, at risk for the development of Parkinson's disease including REM sleep behavior disorder and/or at least one first degree relative with PD or related disorder, and diseases related to Parkinson's disease including the synucleinopathies Lewy Body Dementia and Multiple System Atrophy. * Baseline Hoehn \& Yahr score 1-4 * No contraindications to undergoing screening colonoscopy * Able to give informed consent for study participation Exclusion Criteria: * Clinical features suggestive of a neurodegenerative diagnosis other than synucleinopathy. * Diagnosis of primary mitochondrial disorder, epilepsy, stroke, multiple sclerosis or other neurodegenerative diseases such as Alzheimer's disease, Progressive Supranuclear Palsy (PSP), and Corticobasal syndrome. * Significant concomitant medical disease limiting life expectancy to less than 24 months from study inclusion, or significant and serious concomitant medical disease that is poorly controlled * Signs of active malignant disease or other clinically relevant abnormality on chest x-ray * Active or untreated gastrointestinal disease * Inability to temporarily stop anti-platelet agents or other anti-coagulants without significant risk * Known substance abuse (recent history of abuse of alcohol or other drugs such as barbiturates, cannabinoids and amphetamines) within last 5 years * Contraindication to colonoscopy or associated anesthesia * Pregnancy * In the opinion of the investigator, any other condition regarded as making subject unsuitable for the study
Where it's running
-
Weill Cornell Medicine
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Jacqueline Burre, PhD — Weill Medical College of Cornell University
- Study coordinator: Virginia Gao, MD PhD
- Email: vig9070@med.cornell.edu
- Phone: 929-989-7898
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Tributyrin for PSP: a virtual, early-phase study
This study tests whether tributyrin is safe and tolerable in people with Progressive Supranuclear Palsy who are 45 or older, using virtual visits.
-
A look at why Lewy body conditions cause visual hallucinations
This study tests brain‑imaging in people with Lewy body diseases who do or don’t experience visual hallucinations, and in healthy volunteers, to see how brain networks might create these images.
-
How physical activity might help people with Parkinson’s disease who have DBS-STN implants
This study tests whether adding regular physical activity can help people with Parkinson’s who have DBS-STN stimulation by trying a structured physiotherapy approach alongside standard care.
-
Can hippotherapy improve mobility, gait, balance, and quality of life in people with Parkinson's disease?
This pilot trial tests whether adding horse-assisted therapy to standard rehab helps mobility, gait, balance, and perceived health in adults with Parkinson's disease.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.